Headline
The latest stories from AHA Today.
The Food and Drug Administration yesterday extended the prescriber and pharmacy certification deadlines for the new Clozapine Risk Evaluation and Mitigation Strategy Program, citing ongoing implementation challenges. 鈥淲e will communicate the revised certification deadlines and additional鈥
About 5.5 million Americans will receive premium rebates averaging $129 per family from health insurers who did not meet medical loss ratio requirements in 2014, according to a new report by the Centers for Medicare & Medicaid Services.
Maryjane Wurth will join the AHA on Jan. 28 as chief strategy and relationship officer and president and CEO of Health Forum, leading the organization鈥檚 business development, strategic planning, member relations and personal membership groups. Wurth currently serves as president and CEO of鈥
The New Jersey Hospital Association and the New Jersey Council of Teaching Hospitals have approved an agreement to transition the core functions of NJCTH into NJHA over the next year. 鈥淣JHA and NJCTH have joint members among New Jersey鈥檚 teaching hospitals,鈥 said Leslie鈥
At an AHA-sponsored briefing today on Capitol Hill, hospital leaders shared with congressional staff the many benefits that the 340B Drug Pricing Program brings to vulnerable patients and urged Congress to preserve the program.
In commemoration of National Rural Health Day, the AHA today expressed appreciation to members of the Senate Rural Health Caucus and House Rural Health Care Coalition for their ongoing commitment to America鈥檚 rural hospitals and the communities and patients they serve.
The Centers for Medicare & Medicaid Services seeks comments to inform its development of patient experience of care surveys for the inpatient rehabilitation facility and long-term care hospital quality reporting programs.
About 5.3 million uninsured adults with mental illness or substance use disorders are eligible for Medicaid coverage under the Affordable Care Act, but about half of them live in states that have not expanded Medicaid under the Act, according to a new report by the Substance Abuse and Mental鈥
The Agency for Healthcare Research and Quality today released a toolkit to help hospitals prevent catheter-associated urinary tract infections, which is based on an AHRQ program administered by the AHA鈥檚 Health Research & Educational Trust, among others. More than 1,200 hospitals鈥
The Food and Drug Administration today announced the first approved nasal-spray version of naloxone hydrochloride, a medication that can stop or reverse the effects of an opioid overdose. The agency granted fast-track designation and priority review for the nasal spray; previously the drug was鈥